Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | AGIO |
---|---|---|
09:32 ET | 57212 | 45.77 |
09:34 ET | 35888 | 44.5789 |
09:36 ET | 33848 | 44.635 |
09:38 ET | 41319 | 44.355 |
09:39 ET | 33979 | 44.2425 |
09:41 ET | 33928 | 43.515 |
09:43 ET | 26815 | 43.265 |
09:45 ET | 96061 | 43.785 |
09:48 ET | 5857 | 43.2063 |
09:50 ET | 27341 | 43.13 |
09:52 ET | 14853 | 44.275 |
09:54 ET | 8043 | 43.78 |
09:56 ET | 5031 | 44.73 |
09:57 ET | 6592 | 44.47 |
09:59 ET | 4573 | 44.192 |
10:01 ET | 5048 | 44.195 |
10:03 ET | 8300 | 43.78 |
10:06 ET | 2800 | 43.64 |
10:08 ET | 2618 | 43.365 |
10:10 ET | 3607 | 43.335 |
10:12 ET | 15615 | 43.505 |
10:14 ET | 2752 | 43.655 |
10:15 ET | 2920 | 43.72 |
10:17 ET | 500 | 43.68 |
10:19 ET | 1027 | 43.55 |
10:21 ET | 12227 | 43.54 |
10:24 ET | 5742 | 43.605 |
10:26 ET | 4497 | 43.795 |
10:28 ET | 1880 | 43.855 |
10:30 ET | 11171 | 43.825 |
10:32 ET | 22708 | 43.28 |
10:33 ET | 1981 | 43.09 |
10:35 ET | 2150 | 43.1908 |
10:37 ET | 2761 | 43.33 |
10:39 ET | 1859 | 43.41 |
10:42 ET | 7903 | 43.355 |
10:44 ET | 928 | 43.435 |
10:46 ET | 5984 | 43.595 |
10:48 ET | 3076 | 44 |
10:50 ET | 6072 | 43.74 |
10:51 ET | 1000 | 43.79 |
10:53 ET | 500 | 43.81 |
10:55 ET | 12010 | 43.5 |
10:57 ET | 3710 | 43.22 |
11:00 ET | 9065 | 43.21 |
11:02 ET | 4983 | 42.885 |
11:04 ET | 11802 | 42.475 |
11:06 ET | 8886 | 42.515 |
11:08 ET | 1500 | 42.525 |
11:09 ET | 9902 | 42.755 |
11:11 ET | 11910 | 42.78 |
11:13 ET | 14574 | 42.54 |
11:15 ET | 9207 | 42.325 |
11:18 ET | 15306 | 42.5 |
11:20 ET | 2425 | 42.495 |
11:22 ET | 5854 | 42.0901 |
11:24 ET | 6797 | 42.02 |
11:26 ET | 10743 | 41.975 |
11:27 ET | 6771 | 42.2599 |
11:29 ET | 4833 | 42.295 |
11:31 ET | 7675 | 42.51 |
11:33 ET | 15636 | 42.5 |
11:36 ET | 28268 | 43.14 |
11:38 ET | 2485 | 42.945 |
11:40 ET | 2744 | 42.83 |
11:42 ET | 23546 | 43.2 |
11:44 ET | 25967 | 43.815 |
11:45 ET | 6442 | 44.04 |
11:47 ET | 11927 | 44.38 |
11:49 ET | 18557 | 44.67 |
11:51 ET | 13334 | 44.7 |
11:54 ET | 25536 | 44.9 |
11:56 ET | 2878 | 45.095 |
11:58 ET | 62448 | 45.5 |
12:00 ET | 20134 | 45.51 |
12:02 ET | 5925 | 45.67 |
12:03 ET | 18523 | 44.89 |
12:05 ET | 8214 | 44.62 |
12:07 ET | 3358 | 44.62 |
12:09 ET | 2892 | 44.53 |
12:12 ET | 1858 | 44.55 |
12:14 ET | 6066 | 44.33 |
12:16 ET | 400 | 44.57 |
12:18 ET | 2494 | 44.595 |
12:20 ET | 11859 | 44.295 |
12:21 ET | 5047 | 44.17 |
12:23 ET | 300 | 44.12 |
12:25 ET | 400 | 44.175 |
12:27 ET | 10209 | 44.245 |
12:30 ET | 2532 | 44.23 |
12:32 ET | 114 | 44.22 |
12:34 ET | 3315 | 44.13 |
12:36 ET | 1100 | 44.11 |
12:38 ET | 6877 | 44.23 |
12:39 ET | 2137 | 44.25 |
12:43 ET | 407 | 44.3147 |
12:45 ET | 2673 | 44.255 |
12:48 ET | 700 | 44.255 |
12:50 ET | 34972 | 44.71 |
12:52 ET | 1635 | 44.81 |
12:54 ET | 2526 | 44.63 |
12:56 ET | 1300 | 44.62 |
12:57 ET | 1394 | 44.595 |
12:59 ET | 700 | 44.71 |
01:01 ET | 823 | 44.715 |
01:03 ET | 800 | 44.7 |
01:06 ET | 1500 | 44.85 |
01:08 ET | 100 | 44.82 |
01:10 ET | 13226 | 45.11 |
01:12 ET | 1187 | 45.085 |
01:14 ET | 3067 | 45.025 |
01:15 ET | 400 | 45.09 |
01:17 ET | 2190 | 44.99 |
01:19 ET | 2102 | 45.18 |
01:21 ET | 100 | 45.13 |
01:24 ET | 2211 | 44.945 |
01:26 ET | 1610 | 45.015 |
01:28 ET | 2900 | 44.9 |
01:30 ET | 2476 | 44.925 |
01:32 ET | 400 | 44.925 |
01:33 ET | 3787 | 44.85 |
01:35 ET | 2172 | 44.89 |
01:37 ET | 1300 | 44.76 |
01:39 ET | 1200 | 44.66 |
01:42 ET | 411 | 44.61 |
01:44 ET | 1400 | 44.765 |
01:46 ET | 200 | 44.77 |
01:48 ET | 3620 | 44.97 |
01:51 ET | 1300 | 44.99 |
01:53 ET | 1277 | 44.99 |
01:55 ET | 2831 | 44.99 |
01:57 ET | 100 | 44.99 |
02:00 ET | 300 | 44.98 |
02:02 ET | 1402 | 45 |
02:04 ET | 300 | 44.99 |
02:06 ET | 1200 | 45.015 |
02:08 ET | 2485 | 44.94 |
02:09 ET | 1560 | 45.075 |
02:11 ET | 300 | 45.055 |
02:13 ET | 620 | 45.095 |
02:15 ET | 2795 | 45.04 |
02:18 ET | 400 | 45.1 |
02:20 ET | 500 | 45.02 |
02:22 ET | 1854 | 45.085 |
02:24 ET | 500 | 45.065 |
02:26 ET | 4658 | 45.03 |
02:27 ET | 6353 | 45 |
02:29 ET | 3033 | 45.14 |
02:31 ET | 200 | 45.13 |
02:33 ET | 3955 | 45.05 |
02:36 ET | 300 | 45.06 |
02:38 ET | 600 | 45.05 |
02:40 ET | 5110 | 45.05 |
02:42 ET | 945 | 45.0094 |
02:44 ET | 800 | 45.075 |
02:45 ET | 400 | 45.065 |
02:49 ET | 800 | 45.05 |
02:51 ET | 1600 | 45.17 |
02:54 ET | 3800 | 45.21 |
02:56 ET | 1512 | 45.125 |
02:58 ET | 3367 | 45.245 |
03:00 ET | 200 | 45.275 |
03:02 ET | 5293 | 45.27 |
03:03 ET | 8198 | 45.41 |
03:05 ET | 1410 | 45.55 |
03:07 ET | 20560 | 46.11 |
03:09 ET | 1972 | 45.78 |
03:12 ET | 1495 | 45.69 |
03:14 ET | 1745 | 45.5 |
03:16 ET | 2520 | 45.598 |
03:18 ET | 400 | 45.55 |
03:20 ET | 304 | 45.51 |
03:21 ET | 2190 | 45.63 |
03:23 ET | 1307 | 45.67 |
03:25 ET | 100 | 45.765 |
03:27 ET | 37611 | 46.04 |
03:30 ET | 2892 | 46.015 |
03:32 ET | 8114 | 45.97 |
03:34 ET | 25214 | 46.01 |
03:36 ET | 15191 | 46.01 |
03:38 ET | 24068 | 46.085 |
03:39 ET | 4102 | 46.01 |
03:41 ET | 14902 | 45.74 |
03:43 ET | 3983 | 45.45 |
03:45 ET | 18062 | 45.64 |
03:48 ET | 11022 | 45.65 |
03:50 ET | 6366 | 45.6405 |
03:52 ET | 17243 | 45.69 |
03:54 ET | 16761 | 45.76 |
03:56 ET | 15691 | 46.01 |
03:57 ET | 18819 | 45.81 |
03:59 ET | 139728 | 45.61 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Agios Pharmaceuticals Inc | 2.7B | -7.0x | --- |
Janux Therapeutics Inc | 2.6B | -50.5x | --- |
Geron Corp | 2.7B | -12.7x | --- |
SpringWorks Therapeutics Inc | 2.8B | -7.3x | --- |
Protagonist Therapeutics Inc | 2.8B | 16.9x | --- |
Immunitybio Inc | 2.5B | -4.2x | --- |
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and delivering transformative therapies for patients living with rare diseases. It markets a first-in-class pyruvate kinase (PK) activator for adults with PK deficiency, the first disease-modifying therapy for debilitating hemolytic anemia. Its lead product candidate in its genetically defined disease (GDD) portfolio, PYRUKYND (Mitapivat), is an activator of both wild-type and a variety of mutant pyruvate kinase (PK) enzymes, for the treatment of hemolytic anemias. The Mitapivat is an orally available small molecule and a potent activator of the pyruvate kinase R (PKR) enzymes. In addition, it is also evaluating mitapivat for the treatment of alpha- and beta- thalassemia and sickle cell disease (SCD) in ongoing clinical trials. The Company is also developing AG-946, a clinical-stage oral activator of PKR enzymes for the treatment of hemolytic anemias and other indications, including SCD.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.7B |
---|---|
Revenue (TTM) | $31.3M |
Shares Outstanding | 56.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.75 |
EPS | $-6.49 |
Book Value | $14.50 |
P/E Ratio | -7.0x |
Price/Sales (TTM) | 84.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,293.88% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.